| Primary |
| Acute Myocardial Infarction |
40.6% |
| Myocardial Infarction |
16.1% |
| Drug Use For Unknown Indication |
10.8% |
| Product Used For Unknown Indication |
8.6% |
| Pulmonary Embolism |
4.2% |
| Electrocardiogram St Segment Elevation |
3.9% |
| Ischaemic Stroke |
3.1% |
| Chest Pain |
2.8% |
| Thrombolysis |
2.5% |
| Acute Coronary Syndrome |
1.7% |
| Angina Pectoris |
1.1% |
| Hypertension |
1.1% |
| Bradycardia |
0.6% |
| Embolism |
0.6% |
| Intracardiac Thrombus |
0.6% |
| Resuscitation |
0.6% |
| Shock |
0.6% |
| Anticoagulant Therapy |
0.3% |
| Atrioventricular Block Complete |
0.3% |
| Blood Pressure Decreased |
0.3% |
|
| Death |
43.8% |
| Electrocardiogram St Segment Elevation |
8.9% |
| Drug Ineffective |
8.3% |
| Haemorrhage Intracranial |
5.3% |
| Chest Pain |
4.7% |
| Myocardial Infarction |
4.7% |
| Product Quality Issue |
3.0% |
| Ventricular Fibrillation |
2.4% |
| Ventricular Tachycardia |
2.4% |
| Cardiogenic Shock |
1.8% |
| Electrocardiogram Abnormal |
1.8% |
| Haemorrhage |
1.8% |
| Infarction |
1.8% |
| Oesophageal Rupture |
1.8% |
| Sepsis |
1.8% |
| Arrhythmia |
1.2% |
| Atrophy |
1.2% |
| Brain Death |
1.2% |
| Cardiac Aneurysm |
1.2% |
| Cardiac Arrest |
1.2% |
|
| Secondary |
| Acute Myocardial Infarction |
20.9% |
| Myocardial Infarction |
20.9% |
| Electrocardiogram St Segment Elevation |
11.8% |
| Thrombolysis |
8.2% |
| Atrioventricular Block |
7.3% |
| Chest Pain |
4.5% |
| Acute Coronary Syndrome |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Angina Pectoris |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Atrioventricular Block Complete |
1.8% |
| Coronary Artery Stenosis |
1.8% |
| Lung Neoplasm Malignant |
1.8% |
| Metastases To Liver |
1.8% |
| Thrombosis |
1.8% |
| Analgesic Therapy |
0.9% |
| Cardiogenic Shock |
0.9% |
| Coronary Angioplasty |
0.9% |
| Essential Hypertension |
0.9% |
| Insomnia |
0.9% |
|
| Death |
16.1% |
| Ventricular Fibrillation |
12.9% |
| Cerebral Haemorrhage |
9.7% |
| Chest Pain |
9.7% |
| Drug Ineffective |
6.5% |
| Haemorrhage Intracranial |
6.5% |
| Hypotension |
6.5% |
| Intraventricular Haemorrhage |
6.5% |
| Product Quality Issue |
6.5% |
| Cardiogenic Shock |
3.2% |
| Haematuria |
3.2% |
| Overdose |
3.2% |
| Shock |
3.2% |
| Subarachnoid Haemorrhage |
3.2% |
| Visual Acuity Reduced |
3.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
63.2% |
| Pneumonia Aspiration |
10.5% |
| Acute Myocardial Infarction |
5.3% |
| Blood Triglycerides Increased |
5.3% |
| Klebsiella Infection |
5.3% |
| Pneumonia |
5.3% |
| Respiratory Arrest |
5.3% |
|
| Low Density Lipoprotein Increased |
50.0% |
| Shock |
50.0% |
|
| Interacting |
| Acute Myocardial Infarction |
45.5% |
| Myocardial Infarction |
36.4% |
| Chest Pain |
9.1% |
| Hypertension |
9.1% |
|
| Oesophageal Mass |
50.0% |
| Subarachnoid Haemorrhage |
50.0% |
|
